Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2)
- 1 February 1989
- Vol. 56 (3) , 369-377
- https://doi.org/10.1016/0092-8674(89)90240-7
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Synthetic CD4 Peptide Derivatives That Inhibit HIV Infection and CytopathicityScience, 1988
- Location and Chemical Synthesis of a Binding Site for HIV-1 on the CD4 ProteinScience, 1988
- Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptorCell, 1987
- Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.Journal of Clinical Investigation, 1986
- Tissue-specific phosphorylation of complement receptors CR1 and CR2.The Journal of Experimental Medicine, 1986
- Protection of cottontop tamarins against Epstein–Barr virus-induced malignant lymphoma by a prototype subunit vaccineNature, 1985
- Growth control of activated, synchronized murine B cells by the C3d fragment of human complementNature, 1985
- Adaptation of Lymphadenopathy Associated Virus (LAV) to Replication in EBV-Transformed B Lymphoblastoid Cell LinesScience, 1984
- Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.The Journal of Experimental Medicine, 1983
- Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein–Barr virus-induced B-cell linesNature, 1981